- Home
- AMN vs CSTL Comparison
AMN vs CSTL Comparison
Compare AMN & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMN
- CSTL
- Stock Information
- Founded
- AMN 1985
- CSTL 2007
- Country
- AMN United States
- CSTL United States
- Employees
- AMN N/A
- CSTL N/A
- Industry
- AMN Assisted Living Services
- CSTL Medical Specialities
- Sector
- AMN Health Care
- CSTL Health Care
- Exchange
- AMN Nasdaq
- CSTL Nasdaq
- Market Cap
- AMN 936.6M
- CSTL 946.1M
- IPO Year
- AMN 2001
- CSTL 2019
- Fundamental
- Price
- AMN $25.84
- CSTL $29.81
- Analyst Decision
- AMN Hold
- CSTL Strong Buy
- Analyst Count
- AMN 8
- CSTL 7
- Target Price
- AMN $48.33
- CSTL $37.57
- AVG Volume (30 Days)
- AMN 1.4M
- CSTL 467.0K
- Earning Date
- AMN 11-07-2024
- CSTL 11-04-2024
- Dividend Yield
- AMN N/A
- CSTL N/A
- EPS Growth
- AMN N/A
- CSTL N/A
- EPS
- AMN 1.39
- CSTL 0.21
- Revenue
- AMN $3,067,341,000.00
- CSTL $311,878,000.00
- Revenue This Year
- AMN N/A
- CSTL $49.05
- Revenue Next Year
- AMN N/A
- CSTL N/A
- P/E Ratio
- AMN $18.59
- CSTL $141.70
- Revenue Growth
- AMN N/A
- CSTL 62.43
- 52 Week Low
- AMN $23.37
- CSTL $16.97
- 52 Week High
- AMN $80.22
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- AMN 31.50
- CSTL 45.16
- Support Level
- AMN $24.39
- CSTL $27.24
- Resistance Level
- AMN $26.68
- CSTL $29.02
- Average True Range (ATR)
- AMN 2.29
- CSTL 1.93
- MACD
- AMN -0.36
- CSTL -0.46
- Stochastic Oscillator
- AMN 12.97
- CSTL 29.88
About AMN AMN Healthcare Services Inc
AMN Healthcare Services is one of the largest healthcare staffing company in the United States. In 2023, it offered more than 13,000 nurses and allied healthcare full-time workers with provider clients nationwide. About two thirds of its business is generated from its temporary nursing division; the other third is generated from its physician placement and technology-backed workplace solutions divisions.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.